Adjuvance Technologies, Inc., AKA Adjuvance

United States of America

Back to Profile

1-22 of 22 for Adjuvance Technologies, Inc., AKA Adjuvance Sort by
Query
Aggregations
Jurisdiction
        United States 11
        World 10
        Canada 1
Date
2026 (YTD) 2
2025 1
2024 1
2023 4
2022 2
See more
IPC Class
A61K 39/39 - Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants 16
A61K 39/00 - Medicinal preparations containing antigens or antibodies 10
A61K 31/704 - Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin, digitoxin 8
C07J 63/00 - Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms 6
A61K 31/7024 - Esters of saccharides 5
See more
Status
Pending 6
Registered / In Force 16
Found results for  patents

1.

VACCINES

      
Application Number 18552863
Status Pending
Filing Date 2022-04-13
First Publication Date 2026-04-30
Owner ADJUVANCE TECHNOLOGIES, INC. (USA)
Inventor
  • Martin, J. Tyler
  • Wenger, Jared William
  • Farris, Eric Jon
  • Frenchick (deceased), Patrick J.
  • Lampe, Anna Therese

Abstract

The present application relates to triterpene glycoside saponin-derived adjuvants, TLR4 agonists and antagonists, TLR9 agonists and antagonists, and combinations thereof, as well as pharmaceutical compositions comprising the foregoing and methods of making and of using the foregoing in the treatment of certain diseases.

IPC Classes  ?

  • A61K 39/39 - Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
  • A61K 31/704 - Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin, digitoxin
  • A61K 39/00 - Medicinal preparations containing antigens or antibodies
  • A61K 39/215 - Coronaviridae, e.g. avian infectious bronchitis virus
  • A61K 39/25 - Varicella-zoster virus
  • A61P 31/22 - Antivirals for DNA viruses for herpes viruses
  • C12N 7/00 - Viruses, e.g. bacteriophagesCompositions thereofPreparation or purification thereof

2.

TRITERPENE SAPONIN ANALOGUES

      
Application Number 19431654
Status Pending
Filing Date 2025-12-23
First Publication Date 2026-04-30
Owner
  • ADJUVANCE TECHNOLOGIES, INC. (USA)
  • MEMORIAL SLOAN KETTERING CANCER CENTER (USA)
Inventor
  • Livingston, Philip
  • Ragupathi, Govind
  • Gardner, Jeffrey
  • Martin, J Tyler

Abstract

The present application relates to triterpene glycoside saponin-derived adjuvants, syntheses thereof, and intermediates thereto. The application also provides pharmaceutical compositions comprising compounds of the present invention and methods of using said compounds or compositions in the treatment of and immunization for infectious diseases.

IPC Classes  ?

  • A61K 39/39 - Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
  • A61K 39/00 - Medicinal preparations containing antigens or antibodies
  • A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
  • C07H 15/256 - Polyterpene radicals

3.

ADJUVANT COMPOUNDS AND FORMULATIONS

      
Application Number 18708417
Status Pending
Filing Date 2022-11-08
First Publication Date 2025-01-23
Owner ADJUVANCE TECHNOLOGIES, INC. (USA)
Inventor
  • Wenger, Jared William
  • Chauhan, Harsh Vardhan

Abstract

The present application relates to triterpene glycoside saponin-derived adjuvants, syntheses thereof, and intermediates thereto. The application also provides formulations and pharmaceutical compositions comprising compounds of the present invention and methods of using said compounds, formulations, or compositions in the treatment of and immunization for infectious diseases.

IPC Classes  ?

  • A61K 39/39 - Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
  • A61K 39/00 - Medicinal preparations containing antigens or antibodies
  • A61K 39/25 - Varicella-zoster virus

4.

TRITERPENE SAPONIN ANALOGUES

      
Application Number 18733207
Status Pending
Filing Date 2024-06-04
First Publication Date 2024-10-03
Owner
  • ADJUVANCE TECHNOLOGIES, INC. (USA)
  • MEMORIAL SLOAN KETTERING CANCER CENTER (USA)
Inventor
  • Gin, David Y.
  • Chea, Eric
  • Fernandez-Tejada, Alberto
  • Gardner, Jeffrey
  • Lewis, Jason
  • Livingston, Philip
  • Martin, J. Tyler
  • Nordstroem, Lars
  • Pillarsetty, Naga Vara Kishore
  • Ragupathi, Govind
  • Tan, Derek

Abstract

The present application relates to triterpene glycoside saponin-derived adjuvants, syntheses thereof, and intermediates thereto. The application also provides pharmaceutical compositions comprising compounds of the present invention and methods of using said compounds or compositions in the treatment of and immunization for infectious diseases.

IPC Classes  ?

  • C07H 1/00 - Processes for the preparation of sugar derivatives
  • A61K 31/7024 - Esters of saccharides
  • A61K 39/00 - Medicinal preparations containing antigens or antibodies
  • A61K 39/02 - Bacterial antigens
  • A61K 39/08 - Clostridium, e.g. Clostridium tetani
  • A61K 39/10 - BrucellaBordetella, e.g. Bordetella pertussis
  • A61K 39/39 - Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
  • A61P 31/04 - Antibacterial agents
  • C07H 13/04 - Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
  • C07H 13/06 - Fatty acids
  • C07H 13/08 - Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals directly attached to carbocyclic rings
  • C07J 63/00 - Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms

5.

TRITERPENE SAPONIN SYNTHESIS, INTERMEDIATES AND ADJUVANT COMBINATIONS

      
Application Number 18188101
Status Pending
Filing Date 2023-03-22
First Publication Date 2023-11-09
Owner ADJUVANCE TECHNOLOGIES, INC. (USA)
Inventor
  • Chan, Amanda
  • Gardner, Jeffrey
  • Nordstroem, Lars
  • Walkowicz, William
  • Martin, J Tyler
  • Zhang, Weidong

Abstract

The present application relates to triterpene glycoside saponin-derived adjuvants, syntheses thereof, and intermediates thereto. The application also provides pharmaceutical compositions comprising compounds of the present invention and methods of using said compounds or compositions in the treatment of and immunization for infectious diseases.

IPC Classes  ?

  • A61P 31/20 - Antivirals for DNA viruses
  • A61P 31/04 - Antibacterial agents
  • A61K 39/02 - Bacterial antigens
  • A61K 39/09 - Streptococcus
  • A61K 39/29 - Hepatitis virus
  • A61K 39/08 - Clostridium, e.g. Clostridium tetani
  • A61K 39/39 - Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
  • C07H 13/08 - Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals directly attached to carbocyclic rings
  • C07H 1/08 - SeparationPurification from natural products
  • A61K 39/00 - Medicinal preparations containing antigens or antibodies
  • A61K 39/05 - CorynebacteriumPropionibacterium
  • C07H 15/18 - Acyclic radicals, substituted by carbocyclic rings

6.

VACCINES, VACCINE PRIMING, AND ANTIGEN DOSE SPARING

      
Application Number 18011064
Status Pending
Filing Date 2021-06-17
First Publication Date 2023-08-24
Owner ADJUVANCE TECHNOLOGIES, INC. (USA)
Inventor
  • Martin, J. Tyler
  • Farris, Eric Jon
  • Lampe, Anna Therese

Abstract

The present application relates to new vaccines, improved vaccine priming, and antigen dose sparing in connection with triterpene glycoside saponin-derived adjuvants, salt forms thereof, and pharmaceutical compositions, as well as related methods.

IPC Classes  ?

  • A61K 39/39 - Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
  • A61K 39/145 - Orthomyxoviridae, e.g. influenza virus
  • A61K 39/215 - Coronaviridae, e.g. avian infectious bronchitis virus
  • A61K 39/25 - Varicella-zoster virus
  • A61P 31/16 - Antivirals for RNA viruses for influenza or rhinoviruses
  • A61P 31/14 - Antivirals for RNA viruses
  • A61P 31/22 - Antivirals for DNA viruses for herpes viruses

7.

Triterpene saponin analogues

      
Application Number 18180421
Grant Number 12037355
Status In Force
Filing Date 2023-03-08
First Publication Date 2023-07-13
Grant Date 2024-07-16
Owner
  • ADJUVANCE TECHNOLOGIES, INC. (USA)
  • MEMORIAL SLOAN KETTERING CANCER CENTER (USA)
Inventor
  • Gin, David Y.
  • Chea, Eric
  • Fernandez-Tejada, Alberto
  • Gardner, Jeffrey
  • Lewis, Jason
  • Livingston, Philip
  • Martin, J. Tyler
  • Nordstroem, Lars
  • Pillarsetty, Naga Vara Kishore
  • Ragupathi, Govind
  • Tan, Derek

Abstract

The present application relates to triterpene glycoside saponin-derived adjuvants, syntheses thereof, and intermediates thereto. The application also provides pharmaceutical compositions comprising compounds of the present invention and methods of using said compounds or compositions in the treatment of and immunization for infectious diseases.

IPC Classes  ?

  • C07H 1/00 - Processes for the preparation of sugar derivatives
  • A61K 31/7024 - Esters of saccharides
  • A61K 39/02 - Bacterial antigens
  • A61K 39/08 - Clostridium, e.g. Clostridium tetani
  • A61K 39/39 - Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
  • A61P 31/04 - Antibacterial agents
  • C07H 13/04 - Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
  • C07H 13/06 - Fatty acids
  • C07H 13/08 - Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals directly attached to carbocyclic rings
  • C07J 63/00 - Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
  • A61K 39/00 - Medicinal preparations containing antigens or antibodies
  • A61K 39/10 - BrucellaBordetella, e.g. Bordetella pertussis

8.

ADJUVANT COMPOUNDS AND FORMULATIONS

      
Application Number US2022049255
Publication Number 2023/081505
Status In Force
Filing Date 2022-11-08
Publication Date 2023-05-11
Owner ADJUVANCE TECHNOLOGIES, INC. (USA)
Inventor
  • Wenger, Jared, William
  • Chauhan, Harsh, Vardhan

Abstract

The present application relates to triterpene glycoside saponin-derived adjuvants, syntheses thereof, and intermediates thereto. The application also provides formulations and pharmaceutical compositions comprising compounds of the present invention and methods of using said compounds, formulations, or compositions in the treatment of and immunization for infectious diseases.

IPC Classes  ?

  • A61K 31/7024 - Esters of saccharides
  • A61K 31/70 - CarbohydratesSugarsDerivatives thereof
  • A61K 39/39 - Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
  • C07H 15/18 - Acyclic radicals, substituted by carbocyclic rings
  • A61K 31/704 - Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin, digitoxin

9.

Varicella zoster

      
Application Number 17774637
Grant Number 12673101
Status In Force
Filing Date 2020-11-04
First Publication Date 2022-12-29
Grant Date 2026-07-07
Owner ADJUVANCE TECHNOLOGIES, INC. (USA)
Inventor
  • Martin, J Tyler
  • Wenger, Jared William
  • Farris, Eric Jon
  • Frenchick, Patrick J
  • Lampe, Anna Therese

Abstract

The present application relates to compositions capable of inducing an immune response against Varicella zoster virus, methods of administering such compositions, and methods of producing such compositions.

IPC Classes  ?

  • A61K 39/25 - Varicella-zoster virus
  • A61K 39/00 - Medicinal preparations containing antigens or antibodies
  • A61K 39/39 - Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants

10.

VACCINES

      
Application Number US2022024594
Publication Number 2022/221393
Status In Force
Filing Date 2022-04-13
Publication Date 2022-10-20
Owner ADJUVANCE TECHNOLOGIES, INC. (USA)
Inventor
  • Martin, J, Tyler
  • Wenger, Jared, William
  • Farris, Eric, Jon
  • Lampe, Anna, Therese

Abstract

The present application relates to triterpene glycoside saponin-derived adjuvants, TLR4 agonists and antagonists, TLR9 agonists and antagonists, and combinations thereof, as well as pharmaceutical compositions comprising the foregoing and methods of making and of using the foregoing in the treatment of certain diseases.

IPC Classes  ?

  • C07J 63/00 - Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
  • A61K 31/70 - CarbohydratesSugarsDerivatives thereof
  • C07H 15/24 - Condensed ring systems having three or more rings

11.

VACCINES, VACCINE PRIMING, AND ANTIGEN DOSE SPARING

      
Application Number US2021037907
Publication Number 2021/257884
Status In Force
Filing Date 2021-06-17
Publication Date 2021-12-23
Owner ADJUVANCE TECHNOLOGIES, INC. (USA)
Inventor
  • Martin, J., Tyler
  • Farris, Eric, Jon
  • Lampe, Anna, Therese

Abstract

The present application relates to new vaccines, improved vaccine priming, and antigen dose sparing in connection with triterpene glycoside saponin-derived adjuvants, salt forms thereof, and pharmaceutical compositions, as well as related methods.

IPC Classes  ?

  • A61K 31/715 - Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkagesDerivatives thereof, e.g. ethers, esters
  • A61K 39/12 - Viral antigens
  • A61K 39/145 - Orthomyxoviridae, e.g. influenza virus

12.

ADJUVANT COMPOUNDS, SALT FORMS, AND FORMULATIONS

      
Application Number US2021023591
Publication Number 2021/195024
Status In Force
Filing Date 2021-03-23
Publication Date 2021-09-30
Owner ADJUVANCE TECHNOLOGIES, INC. (USA)
Inventor
  • Martin, J. Tyler
  • Wenger, Jared William
  • Parent, Stephan D.
  • Johnson, Courtney S.
  • Farris, Eric Jon
  • Liu, Gui

Abstract

The present application relates to triterpene glycoside saponin-derived adjuvants, syntheses thereof, and intermediates thereto. The application also provides salt forms, formulations, and pharmaceutical compositions comprising compounds of the present invention and methods of using said compounds, salt forms, or compositions in the treatment of and immunization for infectious diseases.

IPC Classes  ?

  • A61K 31/70 - CarbohydratesSugarsDerivatives thereof
  • A61K 39/39 - Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
  • A61P 37/04 - Immunostimulants

13.

Triterpene saponin analogues

      
Application Number 16608296
Grant Number 12569554
Status In Force
Filing Date 2018-04-25
First Publication Date 2021-09-16
Grant Date 2026-03-10
Owner
  • Adjuvance Technologies, Inc. (USA)
  • Memorial Sloan Kettering Cancer Center (USA)
Inventor
  • Livingston, Philip
  • Ragupathi, Govind
  • Gardner, Jeffrey
  • Martin, J Tyler

Abstract

The present application relates to triterpene glycoside saponin-derived adjuvants, syntheses thereof, and intermediates thereto. The application also provides pharmaceutical compositions comprising compounds of the present invention and methods of using said compounds or compositions in the treatment of and immunization for infectious diseases.

IPC Classes  ?

  • A61K 39/39 - Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
  • A61K 39/00 - Medicinal preparations containing antigens or antibodies
  • A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
  • C07H 15/256 - Polyterpene radicals

14.

VARICELLA ZOSTER

      
Application Number US2020058859
Publication Number 2021/091997
Status In Force
Filing Date 2020-11-04
Publication Date 2021-05-14
Owner ADJUVANCE TECHNOLOGIES, INC. (USA)
Inventor
  • Martin, J Tyler
  • Wenger, Jared William
  • Farris, Eric Jon
  • Frenchick, Patrick J.
  • Lampe, Anna Therese

Abstract

The present application relates to compositions capable of inducing an immune response against Varicella zoster virus, methods of administering such compositions, and methods of producing such compositions.

IPC Classes  ?

  • A61K 38/00 - Medicinal preparations containing peptides
  • A61K 39/39 - Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
  • A61K 39/12 - Viral antigens

15.

Triterpene saponin analogues

      
Application Number 16649892
Grant Number 11324821
Status In Force
Filing Date 2018-10-15
First Publication Date 2020-08-20
Grant Date 2022-05-10
Owner ADJUVANCE TECHNOLOGIES, INC. (USA)
Inventor
  • Martin, J Tyler
  • Gardner, Jeffrey

Abstract

The present application relates to triterpene glycoside saponin-derived adjuvants, syntheses thereof, and intermediates thereto. The application also provides pharmaceutical compositions comprising compounds of the present invention and methods of using said compounds or compositions in the treatment of and immunization for infectious diseases and cancers.

IPC Classes  ?

  • A61K 39/39 - Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
  • A61K 39/00 - Medicinal preparations containing antigens or antibodies
  • A61K 31/704 - Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin, digitoxin

16.

Triterpene saponin analogues

      
Application Number 16827220
Grant Number 10906926
Status In Force
Filing Date 2020-03-23
First Publication Date 2020-07-30
Grant Date 2021-02-02
Owner
  • ADJUVANCE TECHNOLOGIES, INC. (USA)
  • MEMORIAL SLOAN KETTERING CANCER (USA)
Inventor
  • Gin, David Y.
  • Chea, Eric
  • Fernandez-Tejada, Alberto
  • Gardner, Jeffrey
  • Lewis, Jason
  • Livingston, Philip
  • Martin, J. Tyler
  • Nordstroem, Lars
  • Pillarsetty, Naga Vara Kishore
  • Ragupathi, Govind
  • Tan, Derek

Abstract

The present application relates to triterpene glycoside saponin-derived adjuvants, syntheses thereof, and intermediates thereto. The application also provides pharmaceutical compositions comprising compounds of the present invention and methods of using said compounds or compositions in the treatment of and immunization for infectious diseases.

IPC Classes  ?

  • C07H 1/00 - Processes for the preparation of sugar derivatives
  • C07H 13/04 - Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
  • C07H 13/06 - Fatty acids
  • C07H 13/08 - Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals directly attached to carbocyclic rings
  • C07J 63/00 - Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
  • A61P 31/04 - Antibacterial agents
  • A61K 31/7024 - Esters of saccharides
  • A61K 39/08 - Clostridium, e.g. Clostridium tetani
  • A61K 39/02 - Bacterial antigens
  • A61K 39/39 - Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
  • A61K 39/10 - BrucellaBordetella, e.g. Bordetella pertussis
  • A61K 39/00 - Medicinal preparations containing antigens or antibodies

17.

TRITERPENE SAPONIN ANALOGUES

      
Application Number US2018055828
Publication Number 2019/079160
Status In Force
Filing Date 2018-10-15
Publication Date 2019-04-25
Owner ADJUVANCE TECHNOLOGIES, INC. (USA)
Inventor
  • Martin, J Tyler
  • Gardner, Jeffrey

Abstract

The present application relates to triterpene glycoside saponin-derived adjuvants, syntheses thereof, and intermediates thereto. The application also provides pharmaceutical compositions comprising compounds of the present invention and methods of using said compounds or compositions in the treatment of and immunization for infectious diseases and cancers.

IPC Classes  ?

  • C07J 63/00 - Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
  • A61K 31/70 - CarbohydratesSugarsDerivatives thereof
  • C07H 15/24 - Condensed ring systems having three or more rings

18.

TRITERPENE SAPONIN ANALOGUES

      
Application Number US2018029314
Publication Number 2018/200645
Status In Force
Filing Date 2018-04-25
Publication Date 2018-11-01
Owner ADJUVANCE TECHNOLOGIES, INC. (USA)
Inventor
  • Livingston, Philip
  • Ragupathi, Govind
  • Gardner, Jeffrey
  • Martin, J, Tyler

Abstract

The present application relates to triterpene glycoside saponin-derived adjuvants, syntheses thereof, and intermediates thereto. The application also provides pharmaceutical compositions comprising compounds of the present invention and methods of using said compounds or compositions in the treatment of and immunization for infectious diseases.

IPC Classes  ?

  • A61K 31/704 - Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin, digitoxin
  • A61P 37/04 - Immunostimulants
  • C07H 15/256 - Polyterpene radicals

19.

TRITERPENE SAPONIN ANALOGUES

      
Application Number US2018029333
Publication Number 2018/200656
Status In Force
Filing Date 2018-04-25
Publication Date 2018-11-01
Owner ADJUVANCE TECHNOLOGIES, INC. (USA)
Inventor
  • Gardner, Jeffrey
  • Livingston, Philip
  • Martin, J Tyler

Abstract

The present application relates to triterpene glycoside saponin-derived adjuvants, syntheses thereof, and intermediates thereto. The application also provides pharmaceutical compositions comprising compounds of the present invention and methods of using said compounds or compositions in the treatment of and immunization for infectious diseases.

IPC Classes  ?

  • A61K 31/704 - Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin, digitoxin
  • A61P 37/04 - Immunostimulants
  • C07H 15/256 - Polyterpene radicals

20.

TRITERPENE SAPONIN SYNTHESIS, INTERMEDIATES AND ADJUVANT COMBINATIONS

      
Application Number US2018027462
Publication Number 2018/191598
Status In Force
Filing Date 2018-04-13
Publication Date 2018-10-18
Owner ADJUVANCE TECHNOLOGIES, INC. (USA)
Inventor
  • Gin, David, Y.
  • Chan, Amanda
  • Gardner, Jeffrey
  • Nordstroem, Lars
  • Walkowicz, William
  • Martin, J., Tyler

Abstract

The present application relates to triterpene glycoside saponin-derived adjuvants, syntheses thereof, and intermediates thereto. The application also provides pharmaceutical compositions comprising compounds of the present invention and methods of using said compounds or compositions in the treatment of and immunization for infectious diseases.

IPC Classes  ?

  • A61K 31/704 - Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin, digitoxin
  • A61K 39/39 - Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
  • C07H 1/08 - SeparationPurification from natural products
  • C07H 15/256 - Polyterpene radicals

21.

TRITERPENE SAPONIN ANALOGUES

      
Document Number 03003483
Status In Force
Filing Date 2016-11-04
Open to Public Date 2017-05-11
Grant Date 2022-09-13
Owner
  • MEMORIAL SLOAN KETTERING CANCER CENTER (USA)
  • ADJUVANCE TECHNOLOGIES, INC. (USA)
Inventor
  • Gin, David Y. (deceased)
  • Chea, Eric
  • Fernandez-Tejada, Alberto
  • Gardner, Jeffrey
  • Lewis, Jason
  • Livingston, Philip
  • Martin, J. Tyler
  • Nordstroem, Lars
  • Pillarsetty, Naga Vara Kishore
  • Ragupathi, Govind
  • Tan, Derek

Abstract

The present application relates to triterpene glycoside saponin-derived adjuvants, syntheses thereof, and intermediates thereto. The compounds according to the invention are useful as adjuvants in potentiating an immune response to an antigen in a subject. The application also provides pharmaceutical compositions comprising compounds of the present invention and methods of using said compounds or compositions in the treatment of and immunization for infectious diseases. Compound 1-4 is an exemplary compound according to the invention.

IPC Classes  ?

  • A61K 31/704 - Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin, digitoxin
  • A61K 39/39 - Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
  • A61P 31/00 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
  • A61P 37/04 - Immunostimulants
  • C07H 15/24 - Condensed ring systems having three or more rings
  • C07J 63/00 - Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms

22.

TRITERPENE SAPONIN ANALOGUES

      
Application Number US2016060564
Publication Number 2017/079582
Status In Force
Filing Date 2016-11-04
Publication Date 2017-05-11
Owner ADJUVANCE TECHNOLOGIES, INC. (USA)
Inventor
  • Gin, David, Y.
  • Chea, Eric
  • Fernandez-Tejada, Alberto
  • Gardner, Jeffrey
  • Lewis, Jason
  • Livingston, Philip
  • Martin, J, Tyler
  • Nordstroem, Lars
  • Pillarsetty, Naga Vara, Kishore
  • Ragupathi, Govind
  • Tan, Derek

Abstract

The present application relates to triterpene glycoside saponin-derived adjuvants, syntheses thereof, and intermediates thereto. The application also provides pharmaceutical compositions comprising compounds of the present invention and methods of using said compounds or compositions in the treatment of and immunization for infectious diseases.

IPC Classes  ?

  • A61K 31/704 - Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin, digitoxin
  • A61K 31/7024 - Esters of saccharides
  • C07H 13/08 - Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals directly attached to carbocyclic rings
  • C07H 15/24 - Condensed ring systems having three or more rings